Protocol Ledger

NCT06372964 · Phase III · RECRUITING

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Interventional Phase III clinical trial protocol NCT06372964 sponsored by Intra-Cellular Therapies in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-05-14 Enrollment: 384 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06372964
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)384 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06372964
Protocol FieldVerified Registry Value
NCT IdentifierNCT06372964
Consolidated Lead SponsorIntra-Cellular Therapies
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment384 participants (ESTIMATED)
Registered Start Date2024-05-14
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06372964
Hospital Research SiteLocationSite Profile
Advanced Research Center, Inc.Anaheim, CAOpen Hospital Dossier ->
UC Davis Comprehensive Cancer CenterSacramento, CAOpen Hospital Dossier ->
UC San Diego Health and Moores Cancer CenterSan Diego, CAOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI